| Time | Topics | Speaker/s | Discussant |
|
16:30
-
16:36
|
Factors Influencing Big-Bubble Formation During Deep Anterior Lamellar Keratoplasty in Keratoconus
|
Seyed hashem Daryabari, MD
|
Mohammad Naser Hashemian, MD
|
|
16:39
-
16:45
|
Big-Bubble Deep Anterior Lamellar Keratoplasty Using Central Versus Peripheral Air Injection: a Clinical Trial
|
Seyed hashem Daryabari, MD
|
Alireza Eslampoor, MD
|
|
16:48
-
16:54
|
Gelatin Scaffold for Conjunctival Tissue Engineering
|
Shima Dehghani, MD
|
Sara Shafiei, PhD
|
|
16:57
-
17:03
|
Conjunctival Reconstruction Using Nano-Composites of Chitosan/ Polyethylene Oxide and Nano-Cellulose Crystal: in Vitro/ in Vivo Evaluation
|
Shima Dehghani, MD
|
Somayeh Asadi, PhD
|
|
17:06
-
17:12
|
Short-Term Effects of Extremely Low-Frequency Pulsed Electromagnetic Field and Pulsed Low-Level Laser Therapy on Rabbit Model of Corneal Alkali Burn
|
Mozhgan Rezaei Kanavi, MD
|
Masoud Houshmand, PhD
|
|
17:15
-
17:21
|
Higher -Order Aberrations Changes After Customized Femtolaser Assisted LASIK Versus Laser Assisted Subepithelial Keratectomy for the Correction of High Myopia and Astigmatism
|
Seyed Javad Hashemian, MD
|
Farid Karimian, MD
|
|
17:24
-
17:30
|
Preparation, Characterization, and in Vivo Evaluation of Solid Lipid Nanoparticles Containing Diclofenac After Intravitreal Administration
|
Mojtaba Abrishami, MD
|
Reyhaneh Varshochian, PhD
|
|
17:33
-
17:39
|
Intravitreal Clonidine as a Neuroprotective Agent, Safety Dose Determination in Rabbits’ Eyes
|
Homayoun Nikkhah, MD
|
Reyhaneh Varshochian, PhD
|
|
17:42
-
17:48
|
Preparation and in Vivo Evaluation of Nanoliposomes Containing Melphalan After Intravitreal Injection
|
Mojtaba Abrishami, MD
|
Ayyoob Arpanaei, PhD
|
|
17:51
-
17:57
|
Ocular Safety of Intravitreal Anti Connective Tissue Growth Factor Neutralizing Antibody
|
Tahmineh Motevasseli, MD
|
Kamran Mousavi, PhD
|